The Safety Lancet Market in Europe, the Middle East, and Africa (EMEA) is encountering critical growth, driven by the rising emphasis on blood safety in healthcare rehearses. As awareness of bloodborne diseases rises, the demand for safety lancets as a more secure and more helpful alternative for blood collection is developing across the district.
The predominance of constant illnesses, like diabetes and cardiovascular conditions, is a key variable impacting the safety lancet market in EMEA. Patients with persistent illnesses frequently require incessant blood testing, and safety lancets offer a dependable and easy to use answer for healthcare experts and patients the same.
Continuous developments in safety lancet innovation are forming market elements. The advancement of lancets with features like a single prick activation, flexible penetration acuity, and automatic withdrawal is upgrading client experience, making blood collection more effective and less painful.
The rising pattern of home healthcare is impacting market elements, with safety lancets being embraced for at-home blood collection. Patients are progressively dealing with their health at home, and safety lancets give a viable answer for self-checking, adding to market growth.
Rigid regulatory standards with respect to blood collection practices and patient safety are molding the safety lancet market in EMEA. Adherence to regulatory prerequisites is fundamental for makers to guarantee the safety and viability of their items, cultivating trust among healthcare experts.
The variety in healthcare framework across the EMEA district impacts the reception and utilization patterns of safety lancets. Variations in healthcare frameworks and practices add to a powerful market landscape, with a requirement for versatile and versatile arrangements.
Europe, The Middle East & Africa Safety Lancet market size was valued at USD 1.5 billion in 2023. The Europe, The Middle East & Africa Safety Lancet market industry is projected to grow from USD 1.8 billion in 2024 to USD 3.0 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 7.22% during the forecast period (2023 - 2032).
Increase in the prevalence of diabetes, and high growth prospects in emerging countries are propelling the growth of the market.
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
The increasing incidences of diabetes worldwide are driving the growth of the safety lancet market. Safety lancets are used for blood glucose monitoring and medication administration in diabetic patients. As the prevalence of diabetes continues to rise, the demand for safety lancets is also increasing. Additionally, the growing awareness about the importance of regular monitoring of blood glucose levels in diabetic patients is contributing to the growth of the safety lancet market. Regular blood glucose monitoring is essential for managing diabetes and preventing complications, leading to a higher adoption of safety lancets among diabetic patients. For instance, according to the British Diabetic Association, about 73 million were diagnosed with diabetes in 2021, and 27 million adults were undiagnosed.
Moreover, advancements in technology have led to the development of safer and more user-friendly safety lancets, further fueling the growth of the market. These innovative products offer improved comfort and convenience for patients, encouraging more individuals to use safety lancets for blood glucose monitoring. Overall, the increasing prevalence of diabetes, rising awareness about the importance of blood glucose monitoring, and technological advancements in safety lancets are driving the growth of the safety lancet market.
The Europe, The Middle East & Africa Safety Lancet market segmentation, based on type, includes Push Button Safety Lancet, Pressure Activated Safety Lancet and Side Button Safety Lancet. The Push Button Safety Lancet segment dominated the market in the base year, i.e., 2023, and is the fastest-growing segment during the forecast period, 2024–2032. This is due to the increased safety, and push-button mechanism often delivers a faster and more precise puncture, which some users find less painful than using a traditional lancet.
The Europe, The Middle East & Africa Safety Lancet market is segmented, based on end user, into Hospitals & Clinics, Diagnostic Centers and Pathology Laboratories, Home Diagnostics and Others. The Hospitals & Clinics segment held the majority of the market and is the fastest-growing segment during the forecast year due to the growing demand for frequent glucose testing, hemoglobin testing, cholesterol testing, allergy testing, coagulation testing, and neonatal screening across the region is driving the growth of market.
FIGURE 2: Europe, The Middle East & Africa Safety Lancet, By End User, 2023 & 2032 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review
By region, the study segments the market into Europe, and Middle East. In Safety Lancet market Europe held the largest market share in 2023 due to the increasing adoption of Safety Lancets in healthcare facilities and rising awareness about preventing needle-stick injuries among healthcare professionals. Additionally, the stringent regulatory guidelines pertaining to the safe disposal of medical waste have also contributed to the dominance of the Safety Lancet market in Europe. The market is expected to witness significant growth in the coming years, driven by increasing healthcare expenditure and technological advancements in Safety Lancet devices.
FIGURE 3: Europe, The Middle East & Africa Safety Lancet , By Region, 2022 & 2032 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review
The Middle East & Africa Safety Lancet market accounted for the second-largest market share the increasing prevalence of chronic diseases such as diabetes, which require regular blood glucose monitoring. Additionally, Countries in the Middle East & Africa region, such as the UAE, Saudi Arabia, and South Africa, are focusing on improving their healthcare infrastructure and promoting the use of safety devices to enhance patient and healthcare worker safety. This, in turn, is expected to drive the demand for safety lancets in the region.
Furthermore, increasing healthcare expenditures, growing geriatric population, and rising demand for point-of-care testing are also expected to fuel market growth in the Middle East & Africa region. With advancements in technology and the development of innovative safety lancet products, the market is expected to continue to expand in the coming years.
Some of the key market players in the Eu, Middle East & Africa safety lancet market include Becton Dickinson and Company, Bayer AG, Terumo Corporation, HTL-STREFA, Sarstedt AG & Co., and Accu-Chek (Roche). These companies are continuously investing in research and development to develop innovative products and expand their product portfolio. They are also focusing on strategic collaborations, partnerships, and acquisitions to strengthen their market position and expand their geographic presence.
Competition in the safety lancet market is intense, with companies striving to differentiate their products through features such as ergonomic design, ease of use, and increased safety measures. In addition, there is a growing trend towards the development of technologically advanced safety lancets that provide improved comfort and reduced pain for patients.
Key Companies in the Europe, The Middle East & Africa Safety Lancet Market includes.
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)